Knowledge and behavior of Lebanese parents regarding melanoma prevention in public and private school children

IF 1 Q4 ONCOLOGY

Melanoma Management Pub Date : 2021-12-01 DOI:10.2217/mmt-2021-0002

Léa El Haddad, Tarek Souaid, Diana Kadi, Joya-Rita Hindy, K. Souaid, H. Kourie, R. Tomb

引用次数: 0

Abstract

Aim: Assess the knowledge and behavior of Lebanese parents when it comes to melanoma and its prevention in children. Methods: A survey, to be completed by parents, was sent through children from three schools. Results: During sun exposure only 23.5% of 1012 respondents were always covering enough areas of their children's skin and 74.1% did not always apply sunscreen to their children. Parents of private school children were three times more likely to apply sunscreen to their children when exposed to sun, four times more likely to reapply sunscreen every 2–3 h and 21 times more likely to use a higher sun protection factor. Conclusion: Sun protection in children is insufficient and sunburns are frequent, illustrating the need for melanoma awareness campaigns.

查看原文本刊更多论文

黎巴嫩家长在公立和私立学校儿童黑色素瘤预防方面的知识和行为

目的:评估黎巴嫩父母在儿童黑色素瘤及其预防方面的知识和行为。方法:对三所学校的学生进行问卷调查，问卷由家长填写。结果:在1012名受访者中，只有23.5%的人在孩子暴露在阳光下时总是覆盖足够的皮肤面积，74.1%的人不总是给孩子涂防晒霜。私立学校孩子的父母在孩子暴露在阳光下时给他们涂防晒霜的可能性是其他人的三倍，每2-3小时重新涂一次防晒霜的可能性是其他人的四倍，使用更高防晒系数的可能性是其他人的21倍。结论:儿童防晒不足，晒伤频繁，说明有必要开展黑色素瘤宣传活动。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Melanoma Management ONCOLOGY-

CiteScore

5.10

自引率

0.00%

发文量

审稿时长

13 weeks

期刊介绍： Skin cancer is on the rise. According to the World Health Organization, 132,000 melanoma skin cancers occur globally each year. While early-stage melanoma is usually relatively easy to treat, once disease spreads prognosis worsens considerably. Therefore, research into combating advanced-stage melanoma is a high priority. New and emerging therapies, such as monoclonal antibodies, B-RAF and KIT inhibitors, antiangiogenic agents and novel chemotherapy approaches hold promise for prolonging survival, but the search for a cure is ongoing. Melanoma Management publishes high-quality peer-reviewed articles on all aspects of melanoma, from prevention to diagnosis and from treatment of early-stage disease to late-stage melanoma and metastasis. The journal presents the latest research findings in melanoma research and treatment, together with authoritative reviews, cutting-edge editorials and perspectives that highlight hot topics and controversy in the field. Independent drug evaluations assess newly approved medications and their role in clinical practice. Key topics covered include: Risk factors, prevention and sun safety education Diagnosis, staging and grading Surgical excision of melanoma lesions Sentinel lymph node biopsy Biological therapies, including immunotherapy and vaccination Novel chemotherapy options Treatment of metastasis Prevention of recurrence Patient care and quality of life.